Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections

…, N Schönfeld, A Roth, G Bettermann… - European …, 2017 - Eur Respiratory Soc
Mycobacterium abscessus is increasingly being recognised as a significant human pathogen,
especially in patients with cystic fibrosis, and the specific M. abscessus subspecies seems …

Mefloquine as a potential drug against multidrug-resistant tuberculosis

…, N Schönfeld, G Bettermann… - European …, 2015 - Eur Respiratory Soc
In the article by Alsaad et al. [1] in a recent issue of the European Respiratory Journal the
authors reviewed six drugs with antimicrobial activity against Mycobacterium tuberculosis (…

[HTML][HTML] Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates

…, S Vesenbeckh, H Mauch, G Bettermann… - Lung India, 2012 - journals.lww.com
Aims: Our aim was to evaluate alternatives in treatment of MDR and XDR TB other than
using second-line drugs. Materials and Methods: We analyzed retrospectively the minimal …

Is delamanid a potential agent in the treatment of diseases caused by Mycobacterium avium-intracellulare?

…, S Vesenbeckh, G Bettermann… - European …, 2016 - Eur Respiratory Soc
Delamanid, a new agent derived from the nitro-dihydro-imidazooxazole class of compounds
that inhibits mycolic acid synthesis, has strong in vitro activity against Mycobacterium …

Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections

…, N Schönfeld, D Krieger, G Bettermann… - European …, 2017 - Eur Respiratory Soc
Recently in this journal, Salfinger and Migliori [1] discussed the accessibility of bedaquiline
drug susceptibility testing and the analysis of minimum inhibitory concentrations (MICs) for …

Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains

…, R Otto-Knapp, L Bös, G Bettermann… - European …, 2015 - Eur Respiratory Soc
We are following the debate about the administration and the preferred dosage of linezolid in
the treatment of multidrug-resistant (MDR) tuberculosis (TB) and extensively drug-resistant (…

Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis

S Vesenbeckh, D Krieger, G Bettermann, N Schönfeld… - Tuberculosis, 2016 - Elsevier
Due to an increase of drug resistant TB, alternative drugs that are not currently listed in the
WHO guidelines on MDR TB treatment are currently being evaluated. Our group tested 100 …

Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation.

…, S Vesenbeckh, N Schönfeld, G Bettermann… - 2016 - cabidigitallibrary.org
In this study, isoniazid minimal inhibitory concentrations (MICs) were determined in 84 clinical
isolates of Mycobacterium tuberculosis with katG mutation Ser315Thr, all of which were …

In vitro susceptibility of Mycobacterium bovis against moxifloxacin.

T Weiss, N Schönfeld, G Bettermann, TG Blum… - 2012 - cabidigitallibrary.org
A retrospective study was conducted to evaluate the in vitro susceptibility and minimum
inhibitory concentrations (MIC) of moxifloxacin (MXF) in Mycobacterium bovis-positive cultures of …

Minimal inhibitory concentrations (MICs) of mefloquine: in vitro activity against MDR-and nonMDR-Tb strains

D Krieger, S Vesenbeckh, N Schoenfeld, G Bettermann… - 2015 - Eur Respiratory Soc
Introduction: Resistances in M. tuberculosis requires the search for alternative drugs.
Mefloquine is used in the treatment of malaria. Methods: We evaluated the in vitro activity of …